# Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis

> **NCT02623959** · PHASE4 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Advanced Cancers
- Malignant Pleural Effusions

## Interventions

- **BEHAVIORAL:** Questionnaires
- **DRUG:** Fentanyl Patch
- **DRUG:** Fentanyl (IV)
- **OTHER:** Saline
- **DRUG:** Doxycycline
- **BEHAVIORAL:** Phone Calls

## Key facts

- **NCT ID:** NCT02623959
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-27
- **Primary completion:** 2017-05-23
- **Final completion:** 2017-05-23
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623959, "Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02623959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*